DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Teradata Corp
TDC
Collegium Pharmaceutical
COLL
Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 6.87%1.91B | 10.86%1.56B | 560.65%1.02B | 37.77%5.57B | -39.52%2.22B | 120.17%1.79B | 187.55%1.41B | 116.77%155M | 575.65%4.04B | 441.21%3.66B |
Net income from continuing operations | 452.44%1.7B | -13.07%1.52B | -75.10%1.55B | 1,235.72%9.03B | -57.61%757M | 225.31%307M | 254.75%1.74B | 614.56%6.22B | 83.90%-795M | 181.52%1.79B |
Operating gains losses | -351.61%-1.01B | 450.97%544M | 82.73%-1.11B | -16,968.89%-7.59B | 1.18%-1.43B | 295.10%403M | -111.38%-155M | -23,840.74%-6.41B | -99.02%45M | -132.52%-1.45B |
Depreciation and amortization | 7.19%313M | -29.58%50M | 3.16%523M | -28.36%2.08B | 108.81%1.21B | -39.42%292M | -86.24%71M | -61.74%507M | 22.97%2.9B | 426.36%579M |
Deferred tax | 661.54%198M | -73.98%51M | 17.34%318M | 38,833.33%1.16B | 424.76%669M | 100.00%26M | 21.74%196M | 834.48%271M | 99.60%-3M | 52.53%-206M |
Other non cash items | -3.73%749M | -6.60%-549M | -272.47%-307M | -45.22%401M | -107.37%-40M | 12.43%778M | -22.91%-515M | 311.90%178M | 149.49%732M | 117.29%543M |
Change In working capital | -173.50%-147M | -164.23%-246M | 134.69%153M | 2.89%1.64B | -41.17%1.5B | 281.82%200M | 158.78%383M | 55.41%-441M | 672.66%1.59B | 110.17%2.54B |
-Change in receivables | -623.64%-864M | 94.95%-56M | -80.36%163M | 142.17%450M | -3.26%563M | 119.10%165M | -70.99%-1.11B | 705.84%830M | -169.69%-1.07B | 266.04%582M |
-Change in inventory | 59.51%-215M | -97.53%15M | 4.63%-1.22B | 20.83%-1.52B | -208.31%-326M | -50.85%-531M | 153.24%608M | -74.18%-1.28B | -529.08%-1.93B | -65.72%301M |
-Change in payables and accrued expense | -75.28%133M | -18.35%316M | 155.22%111M | -109.88%-221M | -275.32%-945M | -8.19%538M | -72.44%387M | 31.40%-201M | 673.33%2.24B | 341.70%539M |
-Change in other working capital | 2,753.57%799M | -205.04%-521M | 434.15%1.1B | 24.91%2.93B | 96.61%2.2B | -94.62%28M | -7.12%496M | 18.50%205M | 310.96%2.35B | 183.08%1.12B |
Cash from discontinued investing activities | -1,291.18%-405M | 29.84%-649M | 92.25%-32M | -120.88%-391M | 9.34%913M | -94.43%34M | -1,667.80%-925M | -211.92%-413M | -56.76%1.87B | -56.17%835M |
Operating cash flow | -17.28%1.51B | 88.25%913M | 483.01%992M | -12.46%5.18B | -30.43%3.13B | 28.11%1.82B | -11.82%485M | 53.42%-259M | 69.95%5.92B | 74.31%4.5B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -58.04%1.09B | -373.68%-2.76B | -39.64%769M | -36.30%6.94B | -76.65%2.06B | 288.92%2.6B | -30.12%1.01B | 3,638.89%1.27B | 214.31%10.89B | 1,488.83%8.82B |
Net PPE purchase and sale | -16.20%-251M | 37.25%-32M | -30.58%-380M | -55.58%-1.51B | -192.59%-948M | -31.71%-216M | 81.04%-51M | -37.91%-291M | -0.62%-968M | -66.15%-324M |
Net business purchase and sale | -34.98%1.78B | -96.69%74M | 28.89%2.61B | 83.73%8.64B | 154.33%1.64B | 901.10%2.73B | -9.79%2.24B | 55.53%2.03B | 15.36%4.7B | -43.38%646M |
Net investment purchase and sale | 89.36%267M | 0.57%176M | 26.67%-1.14B | -12.56%-986M | -18.85%254M | -15.57%141M | 1,558.33%175M | -15.77%-1.56B | 32.09%-876M | 340.77%313M |
Net other investing changes | -1,071.67%-703M | -119.88%-2.98B | -129.16%-319M | -90.17%790M | -86.45%1.11B | -115.27%-60M | -73.24%-1.35B | 359.66%1.09B | 389.22%8.03B | 2,528.19%8.18B |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -39.22%1.49B | -363.75%-4.29B | 144.99%808M | 75.20%3.98B | 150.00%1.7B | 3,561.19%2.45B | -17.47%1.63B | -304.50%-1.8B | -89.38%2.27B | -96.79%678M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 61.75%-1.46B | -149.33%-2.79B | 96.10%-204M | 22.47%-10.61B | 94.81%-449M | -95.39%-3.81B | 32.39%-1.12B | -265.48%-5.23B | 69.75%-13.69B | 73.59%-8.65B |
Net issuance payments of debt | 81.73%-116M | 64.28%-279M | 81.44%-335M | 69.42%-3.4B | 97.72%-183M | 43.81%-635M | -2.76%-781M | -47.71%-1.81B | 69.80%-11.13B | 69.88%-8.02B |
Net common stock issuance | -390.73%-1.54B | -612.38%-2.3B | -4.21%-322M | -17.65%-1.23B | 20.00%-288M | 1.57%-313M | 2.42%-323M | -692.31%-309M | -879.44%-1.05B | -1,700.00%-360M |
Net preferred stock issuance | --0 | --0 | --0 | -3,924.31%-5.8B | --0 | -2,587.50%-2.8B | --0 | ---3B | ---144M | ---40M |
Cash dividends paid | -103.97%-308M | -109.52%-308M | 57.64%-86M | 7.82%-589M | 52.17%-88M | 6.21%-151M | 4.55%-147M | -45.00%-203M | -11.13%-639M | -27.78%-184M |
Net other financing activities | 526.25%501M | -26.32%98M | 526.74%539M | 156.20%408M | 331.91%109M | 133.47%80M | 132.44%133M | 386.67%86M | 90.60%-726M | 99.21%-47M |
Cash from discontinued financing activities | 0 | -122.73%-98M | 0 | -75.31%2B | -99.33%55M | 71.43%-10M | -69.23%-44M | 7,239.29%2B | 5,887.14%8.1B | 3,498.76%8.19B |
Financing cash flow | 61.85%-1.46B | -148.54%-2.89B | 93.69%-204M | -54.22%-8.61B | 13.76%-395M | -92.45%-3.82B | 30.87%-1.16B | -121.52%-3.23B | 87.70%-5.59B | 98.61%-458M |
Net cash flow | ||||||||||
Beginning cash position | 15.53%13.55B | 56.80%19.9B | 3.47%19.76B | 13.25%19.09B | -2.49%12.23B | -11.36%11.73B | -3.13%12.69B | 13.25%19.09B | -55.17%16.86B | -51.30%12.55B |
Current changes in cash | 117.78%1.47B | -541.56%-6.27B | 103.17%205M | -3,176.92%-852M | 61.42%5.92B | 305.17%675M | -404.36%-977M | -75.56%-6.47B | 99.88%-26M | 136.08%3.67B |
Effect of exchange rate changes | 150.00%85M | -685.71%-82M | -193.85%-61M | 132.52%120M | -16.93%211M | 52.38%-170M | 107.33%14M | 186.67%65M | -73.24%-369M | 429.87%254M |
End cash Position | 23.47%15.1B | 15.53%13.55B | 56.80%19.9B | 11.52%18.36B | 11.52%18.36B | -2.49%12.23B | -11.36%11.73B | -3.13%12.69B | 6.03%16.46B | 6.03%16.46B |
Free cash flow | -22.42%1.24B | 112.47%835M | 202.51%571M | -24.42%3.58B | -47.96%2.15B | 36.72%1.6B | 50.00%393M | 31.82%-557M | 100.25%4.74B | 69.03%4.13B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |